Skip to main content

Table 4 Annual mean cost for a patient with asthma

From: Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants

Expenditure Breakdown

Mean cost per Patient (€)

Pharmacological therapy

457.82

Hospitalizations (ordinary admission and Day Hospital)

461.87

Admissions to Emergency Room

5.11

Visits

112.26

Examinations

127.76

Specific immune therapy

31.86

Other

30.21

Annual mean cost

1,226.88